Bill

Bill > H0452


VT H0452

VT H0452
An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program


summary

Introduced
02/28/2025
In Committee
02/28/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Session

Bill Summary

This bill proposes to decriminalize the possession, cultivation, and noncommercial personal use of psilocybin- containing mushrooms by adults 21 years of age and older and establishes the Psilocybin Therapeutic Consultation Program. The Program is tasked with developing an education, training, and consultation model for the safe use of psilocybin-containing mushrooms designed and overseen by health providers. Health providers eligible for licensure include licensed mental health professionals, physicians, nurse practitioners, and other qualified healthcare practitioners as determined by the Program. Providers must complete a certified training program focused on psilocybin use, safety protocols, and integration practices. Licensed providers may offer initial health evaluations to determine the suitability of psilocybin use, guided psilocybin sessions in a safe, controlled environment and protected by State law, and post-session integration support to maximize therapeutic outcomes. H.452

AI Summary

This bill seeks to decriminalize psilocybin-containing mushrooms (a naturally occurring psychedelic substance) for personal use by adults 21 and older, while simultaneously establishing the Psilocybin Therapeutic Consultation Program. The program will create a structured framework for the responsible and safe use of psilocybin under professional guidance, with licensed healthcare providers such as mental health professionals, physicians, and nurse practitioners able to offer comprehensive services. These services include initial health evaluations to assess patient suitability, professionally guided psilocybin sessions in controlled environments, and post-session integration support designed to maximize potential therapeutic benefits. By developing a rigorous training and consultation model, the bill aims to provide a regulated approach to psilocybin use that prioritizes patient safety, professional oversight, and potential mental health treatment applications, moving away from previous criminalization approaches and towards a more nuanced, health-centered perspective on psychedelic substances.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Read first time and referred to the Committee on Human Services (on 02/28/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...